APO 131 (Carbidopa and Levodopa Extended Release 25 mg / 100 mg)
Pill with imprint APO 131 is Red, Round and has been identified as Carbidopa and Levodopa Extended Release 25 mg / 100 mg. It is supplied by Apotex Corp..
Carbidopa/levodopa is used in the treatment of parkinson's disease; restless legs syndrome; neuroleptic malignant syndrome; gtp-ch deficiency and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Carbidopa/levodopa 25 mg / 100 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for APO 131
Carbidopa and Levodopa Extended Release
- Imprint:
- APO 131
- Strength:
- 25 mg / 100 mg
- Color:
- Red
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Dopaminergic antiparkinsonism agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Apotex Corp.
- Inactive Ingredients:
- hypromelloses
magnesium stearate
ferric oxide red
Note: Inactive ingredients may vary.
More about carbidopa/levodopa
- Carbidopa/levodopa Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- 53 Reviews
- Drug class: dopaminergic antiparkinsonism agents
Consumer resources
- Carbidopa and levodopa
- Carbidopa and levodopa enteral
- Carbidopa and Levodopa Orally Disintegrating Tablets
- Carbidopa and Levodopa Sustained-Release Tablets
- Carbidopa and Levodopa Tablets
- ... +4 more
Other brands: Sinemet, Rytary, Sinemet CR, Duopa, Parcopa
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
